Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 333 results for "ranbaxy industries"

BRIEF-Sun Pharmaceutical Industries approves amalgamation of 4...

n"Nov 10 Sun Pharmaceutical Industries Ltd * Says approves scheme of amalgamation of Sun Pharma Medisales, Ranbaxy Drugs Ltd, Gufic Pharma, Vidyut Investments into co Source text: bit.ly/2g0Jbpb Further Reuters UK, 3 weeks ago

4 images for ranbaxy industries

Uranium Investing News, 1 week ago
Financial Express, 1 month ago
Livemint.com, 3 months ago
The Freepress Journal, 4 months ago
Financial Express

Will release salary to ex-Ranbaxy MRs using company app: Sun

Backed by a Bombay High Court order, drug major Sun Pharmaceutical Industries today said it will release salaries of the erstwhile Ranbaxy medical representatives only if they used a company provided software application to report daily activity ...
 Business Standard1 month ago

Sun Pharma, Ranbaxy medical reps called for talks

Email this Print The management of Sun Pharmaceutical Industries has been asked by the office of the assistant labour commissioner, Maharashtra, to come over for a discussion on October 18 with medical representatives (MRs) of the erstwhile ...
 Smart Investor1 month ago
Uranium Investing News

Landmark Court Decision Upheld for Pharmaceutical Industry

, the courts upheld a favorable verdict for AstraZeneca and Ranbaxy, ruling that the companies did not violate antitrust laws several years ago with an alleged pay for delay deal. But these two drug makers aren't the only winners. The ruling is a ...
 Uranium Investing News1 week ago AstraZeneca, Ranbaxy prevail in landmark pay-for-delay case  FiercePharma1 week ago ASTRAZENECA : U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust trial  4 Traders1 week ago U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust ...  Investing.com1 week ago
[x]  

Finasteride Market: Industry Analysis Report, Regional Outlook, Application Development Potential & Forecast, 2016 2024.

"Finasteride market share comprises of Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Dr. Reddys Laboratories and Intas Pharmaceuticals, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, ...
 Digital Journal1 week ago
Sudan News Gazette

Pharmaceutical industry and na...

Pharmaceutical industry CONTINUED FROM MONDAY The competitiveness issues where Nigeria has consistently scored low include infrastructure, access to finance, security, corruption and governance, quality of education, skilled manpower and ...
 Sudan News Gazette3 days ago Pharmaceutical industry and national development - Part 2  The Guardian Nigeria3 days ago
[x]  

SUN PHARMACEUTICAL INDUSTRIES : Pharma strong and healthy

The $4.6 billionSun Pharmaceutical Industries has been at the forefront of the Indian pharma growth story, which has evolved from the sale of low-cost medicines in the largest markets to competing with the largest generic companies globally.
 4 Traders5 days ago ET 500: Sun Pharma strong and healthy  Economic Times5 days ago
SPi World News

Taro Appoints Uday Baldota CEO

HAWTHORNE, N.Y.--( BUSINESS WIRE )-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today the appointment of Mr. Uday Baldota as Chief Executive Officer and as a nominee to Taro's Board of Directors. He is expected to begin his role as ...
 Citybizlist1 week ago Taro Announces Appointment of New CEO and New Board Member Nominations  Business Wire1 week ago TARO PHARMACEUTICAL INDUSTRIES : Announces Appointment of New CEO and New Board Member Nominations  4 Traders1 week ago Taro Taps Sun Pharma CFO as New CEO  BioSpace1 week ago
[x]  

Sun Pharma picks company veteran to tackle U.S. troubles

MUMBAI (NewsRise) -- Sun Pharmaceutical Industries has named company veteran and Chief Financial Officer Uday Baldota as the new chief executive of its U.S. unit, as India's largest drug maker braces for challenging times in its biggest market amid ...
 Nikkei Asian Review1 week ago

Taro appoints Sun Pharma CFO Uday Baldota its CEO

Israel's Taro Pharmaceutical Industries, a subsidiary of Sun Pharma, has appointed Uday Baldota its chief executive officer (CEO). Baldota, who has also been nominated to Taro's board of directors, is expected to begin his role as CEO on or about ...
 Moneycontrol.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less